grey-arrows-planes
31 July 2013EuropeMatt Smith and Jonathan Wills

Accelerating and decelerating patent prosecution in Europe and the UK

The time it takes for a family of patent applications to progress through patent offices around the world is enormously variable. For many applicants in the life sciences field, delays in the patent application procedure are useful since they delay grant costs, and leave the scope of claims uncrystallised, creating uncertainty for third parties. However, where there is an identifiable product to be pushed to market, there may be a need to get enforceable protection quickly.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Europe
9 July 2026   China-headquartered Angelalign failed to convince UPC appellate judges to overturn a ban that affects its ability to offer orthodontic planning software in Europe with certain functionality.
Europe
8 July 2026   UPC judges revoke a patent asserted against the companies over their Comirnaty COVID-19 vaccine, in a ruling that clarified the court’s key principles on exclusive licences, novelty and inventive step.
Europe
6 July 2026   The Unified Patent Court delivers a mixed ruling in a dispute over liquid biopsy technology, overturning a finding that a patent was likely invalid while refusing to grant interim relief because of the patent owner’s delay.